Stock search

Ticker or company name

RMD card

RMD price forecast

ResMed$238,19

P/E now is 21,7. Average over 5 years: 33,4 (range 26–38). The stock is 35% below its history.

Base · FY2031

$545,13+20,3% a year

The base case gives 20,3% a year, above your target of 10%.

Settings

%

No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.

Assumptions by year

FY2027FY2028FY2029FY2030FY2031
Revenue growth, %
Net margin, %
Change in shares, %
Payout ratio, %
P/E low
P/E base
P/E high
Revenue$6,34 bn$7,10 bn$7,96 bn$8,92 bn$10,0 bn
Net income$1,51 bn$1,69 bn$1,89 bn$2,12 bn$2,38 bn
EPS$10,33$11,58$12,99$14,57$16,33

Changed values are highlighted. Bear and bull cases: growth ∓ 3,4%, margin ∓ 2 pp, low and high P/E.

Price at year end

  • Base
  • Bear – Bull
  • now $238,19

The dot is the base case, the line runs from bear to bull, the dashed line is today's price.

Result at the end of FY2031

Bear$328,05

Price change
+37,7%
A year
+8,0%
Fair value today
$218,88
Margin of safety
−8,1%

Base$545,13

Price change
+128,9%
A year
+20,3%
Fair value today
$360,30
Margin of safety
+51,3%

Bull$790,03

Price change
+231,7%
A year
+30,3%
Fair value today
$519,87
Margin of safety
+118,3%

What growth the price implies

For the stock to return 10% a year, revenue must grow 3,7% a year to FY2031 at a 23,8% margin and P/E 33,4.

Growth over 5 years
12,1%
Analyst consensus
no data
In your model
12,1%

Calculated from your assumptions. Not an investment recommendation.

Base · FY2031$545,13+20,3% a year